Lymphocyte Counts in Immune Thrombocytopenic Purpura

NCT03244410 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2017-08-09

No results posted yet for this study

Summary

* immune thrombocytopenic purpura is an acquired autoimmune disorder characterized by increased platelet destruction and decreased platelet number (cooper N et al 2006)
* recent studies have demonstrated that the pathogenesis of ITP envolves multifactorial autoimmune mechanisms of both humoral and cellular immunity and that acute and chronic forms may represent two distinct immunopathological disorders ( cooper N et al 2006) ( Gern Sheimer T 2009 )

Conditions

  • Thrombocytopenic Purpura

Interventions

DIAGNOSTIC_TEST

complete blood picture

complete blood picture

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-31
Primary Completion
2018-12-31
Completion
2019-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03244410 on ClinicalTrials.gov